You are here

IMPROVE-IT

Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug?

Forbes

Fri, 11/21/14 - 10:26 am

Results Of Merck’s Vytorin Trial Delayed A Year

Pharmalot

Mon, 01/11/10 - 11:35 am

clinical trials